Abstract
Nimbamritadi Panchatiktam Kashayam (NPK) is an ayurvedic formulation composed of ingredients with potent anti-viral activities. We studied the interaction energy of 144 phytoconstituents present in NPK against spike receptor-binding domain (RBD) complexed with ACE2 protein (PDB ID: 6LZG) and RNA-dependent RNA polymerase protein (PDB ID: 7BTF) using Biovia Drug Discovery studio. The result indicated that 2,4-hydroxycinnamic acid exerts more significant binding affinities (28.43 kcal/mol) than Umifenovir (21.24 kcal/mol) against spike ACE2. Apigenin exhibited the highest binding affinities (54.63 kcal/mol) compared with Remdesivir (24.52 kcal/mol) against RdRp. An in vitro analysis showed a reduction in the number of lentiviral particles on transfected HEK293T-hACE2 cells as assessed by pseudovirus inhibition assay. At the same time, the tested compounds showed non-toxic up to 100 µg/ml in normal cells by MTT assay. The study highlights the plausible clinical utility of this traditional medicine against SARS CoV2.
Graphical abstract
Avoid common mistakes on your manuscript.
Introduction
COVID 19 is a global pandemic caused by a dreadful pathogen SARS CoV2 (severe acute respiratory syndrome coronavirus - 2), which resembles highly contagious fatal pneumonia with severe acute respiratory distress, which leads to a wide mortality ratio [1]. It is a highly enveloped, positive single-stranded RNA virus with four structural proteins: M protein, N protein, E protein, S protein, and sixteen non-structural proteins [2, 3]. SARS CoV2 mediates endocytosis by adhering the spike protein homotrimers with the ACE2 receptors expressed on the surface of host cells, thereby aiding receptor recognition and membrane fusion [4, 5]. Following the viral entry into the host cell, another critical event involved in the viral lifecycle process is the Replication/transcription complex (RTC). The formation of RTC helps in viral genome replication and subgenomic mRNA synthesis [6]. RNA-dependent RNA polymerase enhances a functional catalytic activity upon the formation of genome replication machinery; thus, it stimulates the frequent addition of hundreds to thousands of nucleotides and enhances elongation [7].
Traditional sources of Ayurveda have significantly contributed to averting the progression of almost all severe illnesses with potential effectiveness. Nimbamritadi Panchatiktam Kashayam (NPK) is an Ayurvedic herbal decoction mainly suggested during the infectious spread of Dengue and Malaria constituted with ingredients of superior anti-viral activities. It includes several herbal constituents such as Azadirachta indica (Neem), Tinospora cordifolia (Amruta), Adhatoda zeylanica (Vasaka), Trichosanthes dioica (Pointed guard), Solanum Xanthocarpum (Kantakari,), etc. which are well known for its anti-viral activities. Among the former mentioned herbal components, Solanum Xanthocarpum (Yellow nightshade) constitutes 2,4-dihydroxycinnamic acid and apigenin. Also, apigenin is present in another herbal plant named Azadirachta indica (Neem) [8,9,10,11,12,13]. Targeting entry and replication of coronavirus with traditional formulation may be an ideal strategy, which can help further develop effective therapeutic interventions against SARS CoV2 [14,15,16,17]. The present study identifies the most active phytochemicals within the formulation targeting the entry and replication pathway of the virus in silico and further confirms with in vitro studies.
Results and discussion
Evaluation of the effect of phytoconstituents against viral entry and viral replication using the in silico method of analysis
Molecular docking is a crucial platform for computer-aided drug design and structure-based biology that helps to predict drug–target interaction concerning binding geometry. Molecular docking favors the interpretation of the behavioral nature of drugs at the binding site and the characterization of drug–target complex [18]. We analyzed the ADMET properties of 90 phytoconstituents, among which 50 passed the ADMETox with critical properties. Finally, around 25 ligands were selected for further molecular docking, and the most active ligands were further subjected to in vitro studies (Figure S1 and Table S4). Lipinski’s rule of five indicates that 2,4-dihydroxycinnamic acid and apigenin possess drug-like properties, and there is no violation of the law (Supporting information Table S1) [19, 20]. In our present work, we determine the binding affinity of various phytoconstituents constituted within Nimbamritadi Panchatiktam Kashayam (NPK) toward spike RBD-ACE2 complex and RdRp compared with standard drugs. Several clinically available repurposed drugs like Chloroquine, Hydroxychloroquine, Umifenovir, and Remdesivir with existing literature were selected as standard drugs for comparison [21,22,23,24].
Results reveal that 2,4-dihydroxycinnamic acid interacts with nine amino acid residues: Asparagine 90 (ASN A:90), Lysine 26 (LYS: 26), Threonine 92 (THR: 92), Proline 389 (PRO: 389), Glutamine 96 (GLU A:96), Asparagine 33 (ASN: 33), Leucine 29 (LEU: 29), Aspartate 30 (ASP: 30), and Valine 93 (VAL: 93). Reports indicate that the amino acids present at the spike RBD-ACE2 interface undergo glycosylation and favor the modifications for binding with the spike receptor-binding domain of SARS CoV2, enhancing the virion tropism [25, 26]. Additionally, 2,4-dihydroxycinnamic acid possesses a strong interaction bond with these amino acids due to two conventional hydrogen bonds. Also, the conventional hydrogen bond of 2,4-dihydroxycinnamic acid with spike ACE2 is at a short distance, making the bond more vital and stable [27]. Conventional hydrogen bonding is reported to be crucial in all types of biomolecular interactions. Thus, it is termed the “master key of molecular recognition.” Moreover, conventional hydrogen bonds are more specific and offer stereo chemical orientation. It is breakable under thermally activated reactions but offers long-term stability toward target–ligand interaction [28]. Similarly, apigenin possesses more amino acid interaction with RdRp and includes three conventional hydrogen bonding at the site of LYS: 545, ARG A: 553, and ARG A: 555. Hydrogen bonding of apigenin with these amino acid residues at the nucleoside triphosphate entry channel makes the bond more robust and can modulate the interaction. Thus, the binding of apigenin may enhance interaction with these amino acid residues and may help introduce the clinical activity of apigenin at the interaction site by inhibiting the activity of RdRp [29]. Physiochemical characterization and secondary structure analysis were done using online bioinformatics tools like ProtParam and SOPMA to identify the best PDB. The results revealed that 6LZG (spike RBD-ACE 2) and 7BTF (RdRp) are suitable PDB IDs for the selected active sites. Selected phytoconstituents docked with determined PDB IDs (6LZG and 7BTF), and the docking scores obtained compared with standard drugs Umifenovir and Remdesivir, respectively [30, 31]. Results indicate that 2,4-dihydroxycinnamic acid and apigenin are the best candidate molecules with PDB ID: 6LZG and 7BTF, respectively, based on docking score and number of amino acid interactions. Additionally, 2,4-dihydroxycinnamic acid and apigenin interact with identical hot spot amino acid residues as in the case of standard drugs like Umifenovir and Remdesivir, respectively. This indicates that they may be clinically promising in combating viral entry and replication of SARS CoV 2 by showing significant interactions with these hot spot amino acid residues present at spike RBD- ACE2 interface and at the RdRp site [25, 26, 29]. (Figs. 1, 2).
In vitro cell proliferation assay and Pseudovirion assay for SARS CoV2
MTT assay
The biological safety of the two most active compounds, apigenin, and 2,4-dihydroxycinnamic acid, was analyzed on Vero cells by MTT. Both the compounds exhibited a dose-dependent cytotoxic effect with IC50 of 87.55 µg/ml and 118.4 µg/ml for apigenin and 2,4-dihydroxycinnamic acid, respectively. However, the low-to-medium concentration range (1–50 µg/ml) did not exhibit a considerable cytotoxic effect. Apigenin and 2,4-dihydroxycinnamic acid exhibited cell viability of 76.92% and 81.16% on Vero cells after 48-h treatment at 50 µg/ml. Finally, based on the cell viability assay, we have selected a non-toxic concentration range of 1–50 µg/ml for both compounds for further in vitro Pseudovirion analysis Figs. 3 and 4 [32].
Pseudovirion assay
Pseudovirion assay offers a safe-effective protocol to study highly infectious and pathogenic viruses like SARS CoV2. SARS CoV2-spike-pseudotyped lentiviral particles produced in transfected HEK293T-hACE2 cells have green fluorescence due to Zsgreen traceable marker. After 48 h treatment with NPK (1: 500 dilutions) upon Pseudovirion infected cell line, it exhibited a significant reduction in the fluorescent marker activity, which denotes its anti-SARS CoV2 effect. Importantly, this pseudovirion neutralization effect is almost similar to the standard virion entry inhibitor, Umifenovir, at 41.89 µM concentration. We evaluated the most active candidates within the NPK as evidenced by in silico. We observed a prominent inhibitory effect on the SARS CoV2 virus after apigenin and 2,4-dihydroxycinnamic acid treatment at 74.0083 µM and 111.01 µM, respectively, Fig. 5.
Several plant-based bioactive compounds exhibit pharmacological activities against various disease ailments [33]. Cinnamic acid derivatives and apigenin are associated with anti-viral effects. In a study by Zhang et al. and his team, apigenin blocked the EV71 infection by disrupting the viral RNA association with hnRNP (heterogeneous nuclear ribonucleoproteins) A1 and A2 proteins. Also, an estimated EC50 value of 10.3 µM and CC50 value of 79 µM for apigenin was found to block the EV71 infection. From the study, Zhang et al. and his team identified that apigenin selectively suppressed the GFP expression. Thus, apigenin was identified as an effective anti-viral agent against EV71 infection [34]. Several scientific reports state that cinnamic acid derivatives have been reported to elicit anti-viral activities. Amano et al. and his research team synthesized seventeen cinnamic acid derivatives and screened them to identify an effective anti-viral compound against the hepatitis C virus. Among the 17 selected compounds, compound 6 was found to suppress the viral replication of genotypes 1b, 2a, 3a, and 4a with an EC50 value of 1.5–8 µM and SI values of 16.2–94.2. Compound 6 is also phosphorylated f Tyr705 in signal transducer and activator of transcription 3 (STAT3). Compound 6 suppressed anti-viral activity but did not inhibit JAK1/2-dependent phosphorylation of STAT3 Tyr705. Furthermore, results suggest that compound-6-dependent elevation of ROS is associated with the inhibition of HCV replication. The induction of oxidative stress by treatment with compound 6 may impair HCV replication by promoting lipid peroxidation. Thus, from the data obtained, the authors suggest that compound 6 significantly inhibits HCV replication via the induction of oxidative stress [35]. Based on the observation, we suppose that NPK and its active phytoconstituents such as apigenin and 2,4-dihydroxycinnamic acid can be developed as a significant anti-SARS CoV2 if further validated with detailed in vitro and in vivo [36].
Conclusion
The results showed that 2,4-dihydroxycinnamic acid from Solanum Xanthocarpum (Yellow nightshade) showed better binding affinities than Umifenovir in case of viral entry. Additionally, apigenin constituted within Solanum Xanthocarpum and Azadirachta indica (Neem) showed marked binding affinities more than Remdesivir toward blocking RNA-dependent RNA polymerase. In vitro SARS CoV2 assay confirmed that apigenin is more potent than 2,4-dihydroxycinnamic acid. Using phytoconstituents as an adjunct medication is another important question of herb–drug interactions requiring detailed experimental and clinical evidence. Another advantage with phytoconstituents is that the generation of adverse effects profiles is very low compared to other clinically available drugs.
Materials and methods
Database used for screening
The natural compound library of approximately 144 ligands constituted in Nimbamritadi Panchatiktam Kashayam (NPK) was taken from ZINC (https://zinc.docking.org) and IMPAAT (Indian Medicinal Plants, Phytochemicals and Therapeutics) (https://cb.imsc.res.in/imppat/home) databases for the best ideal ligands against the reference targets. NPK is a marketed ayurvedic formulation that belongs expectorant category with a wide range of pharmacological activities. Additionally, Ayurvedic physicians advise the usage of NPK for psoriasis and dermatitis. NPK is also known for its blood-purifying action. Anti-viral ingredients mainly constituted within NPK formulation include Azadirachta indica (neem), Tinospora cordifolia (amruta), Adhatoda zeylanica (vasaka), Trichosanthes dioica (pointed guard), Solanum Xanthocarpum (Kantakari), etc. (https://ayurvedapc.blog/2021/02/09). The literature-based survey was conducted to identify the constituents exhibiting the best anti-viral activity within Nimbamritadi Panchatiktam Kashayam. The 2D structures and chemical information of these phytoconstituents were obtained from PubChem, an open chemistry database at the National Institutes of Health (NIH) (https://pubchem.ncbi.nlm.nih.gov/) [37, 38]. These ligands' drug-likeness properties were evaluated using the Lipinski rule to confirm molecular characteristics. The docking studies of selected phytoconstituents against SARS CoV2 with desired protein were performed using the BIOVIA Discovery studio (client version 17.2.0.1.16347). The method includes the identification of active proteins involved in the pathogenesis of SARS CoV2 from RCSB, ligand identification, ligand preparation, and molecular docking study [39].
Drug likeness study
Estimation of drug-likeness features with Lipinski’s rule states that the characteristics like electronic distribution, lipophilic nature, size of the molecule, and flexibility and hydrogen bond properties have a more significant impact on the mechanistic nature of the molecule within a living organism, such as protein affinity and transport, reactivity and toxicity, and metabolic stability. Following Lipinski’s rule, a molecule is considered to possess drug-like activity or is predicted to be membrane-permeable and easily absorbed into the body; it should obey five criteria for drug-likeness mainly molecular weight, AlogP, hydrogen donor and acceptor, and several rotatable bonds [40].
ADMET studies
Lipinski's rule analyzed ADMET properties such as absorption, distribution, metabolism, and excretion for the ligands that passed the drug-likeness properties. The AMDET properties are generally predicted by deeply analyzing physicochemical characteristics such as molecular weight (MW), polar surface area (PSA), lipophilicity (AlogP), Plasma protein binding (PPB), and aqueous solubility (logS) of selected compounds, closely related to certain features of drug molecules like absorption and bioavailability. ADMET studies are performed with ADMET Descriptors and Toxicity Prediction methods in Discovery Studio 2018. The information for establishing and validating these modules was obtained from various literature reports and experimental results [41].
Protein identification structure retrieval
Proteins employed for this study are mainly involved within the critical pathways possessing the mechanism of action of novel coronavirus SARS CoV 2. Experimentally illustrated 3D structures of the proteins like Spike RBD complexed with ACE2 and RNA-dependent polymerase (RdRp) were downloaded RCSB PDB (www.rcsb.org) [42, 43].
Characterization of selected proteins
PDB IDs representing spike RBD complexed with ACE2 and RdRp were set and subjected to ProtParam for computing physical and chemical parameters of proteins entered in Swiss-Prot or TrEMBL like pI value, instability index, half-life period, aliphatic index, and GRAVY. SOPMA is indicated for secondary structure prediction, which identifies the properties like the percentage of different forms of protein, such as alpha-helix, beta-turn, random coil, and so on. Finally, PDB ID: 6LZG representing spike – ACE2 and 7BTF stands for RdRp was selected [43].
Protein preparation
Proteins were prepared using the ‘prepare protein’ module implemented under the ‘Macromolecules’ module of the drug discovery studio. Water molecules and heteroatoms in the co-crystallized structure were removed, and the missing hydrogen atoms were added to the system. Protonation pH of 6.5 to 7.5 within the range of ionization was identified from the protein report. Possible tautomers and conformers for the proteins were predicted and the protein was thus prepared. Prediction of active sites in a protein is an essential strategy before docking. In this study, the accurate prediction of functional sites was done using Biovia Drug discovery studio visualizer 2020 [44].
Ligand preparation
Analysis of Drug likeness property by applying the Lipinski rule helped to filter all the enlisted phytoconstituents concerning factors similar to bioavailability by using a drug discovery studio. The selected ligands were subjected to evaluate ADMEtox properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity parameters) with Biovia drug discovery studio and SWISS ADME http://www.swissadme.ch. Around 25 ligands that have passed the ADMEtox test were further estimated with molecular docking procedures. Filtered ligands and reference ligands, mainly chloroquine, hydroxychloroquine, and umifenovir were prepared by applying the designed ligands module from small molecule implemented in Biovia drug discovery studio [45].
Molecular docking analysis
The protein–ligand docking mechanism of the chosen protein–ligand complexes was performed using BIOVIA Discovery studio (client version 17.2.0.1.16347). We evaluated the interactions of crystal structures of spike RBD ACE2 complex and RdRp, respectively. The receptor structure was typed with the CHARMM force field before docking. Natural ligands, water molecules, and heteroatoms attached to selected proteins were removed as a part of the cleaning protein. Polar hydrogen atoms were added and subjected to the purification process before docking. The pH of the protein was adjusted to almost neutral 7.4 using a protein preparation module. Selected ligands were typed with a CHARMM force field and minimized by applying the smart minimizer minimization algorithm of Discovery Studio 2018, which constitutes about 2000 steps of steepest descent with an RMS gradient tolerance of 3 and conjugate gradient minimization. The active sites were determined from the PDB IDs 6LZG, and 7BTF, and the sphere radius was adjusted. CDOCKER module implemented under receptor–ligand interaction tool within DS is preferred for performing molecular docking. The prepared ligands were docked in the discovered pockets of the PDBs (6LZG and 7BTF) to evaluate the conformational flexibility during the refinement step and to predict CDOCKER ENERGY and CDOCKER INTERACTION ENERGY. In the study, each ligand was subjected to 10 runs in the docking software. Also, the active site of ligands was selected for the study, and in this site, we generated the grid box and further performed molecular docking analysis. The molecules with high docking scores were investigated to identify the molecules compared to the standard drugs hydroxychloroquine, chloroquine, and umifenovir [30, 46,47,48].
In vitro toxicity assay on Vero cells
Chemicals: DMEM, FBS, and antibiotic solution (Gibco, USA), DMSO and MTT (Sigma, USA), 1X PBS (Himedia, India), 96-well tissue culture plates (Himedia, India).
Cell line: African Green Monkey Kidney cells and Vero cells were purchased from NCCS, Pune. The Vero cells were cultured in DMEM supplemented with 10% FBS, 100 µg/ml penicillin, and 100 µg/ml streptomycin, and maintained under an atmosphere of 5% CO2 at 37 °C.
Assay procedure
The phytoconstituents selected from the molecular docking studies namely, 2,4-dihydroxycinnamic acid and apigenin were subjected to in vitro cell proliferation assay followed by trypsinization and pooling of cells into a 15-ml test tube. The cells were seeded [cell density: 1 × 105 cells/ml cells/well (200 µL)] into 96-well plates containing DMEM medium with 10% FBS and 1% antibiotic solution for 24–48 h at 37 °C. The wells were washed with sterile PBS and treated with various concentrations of the samples in a serum-free DMEM medium. Individually, the samples were replicated three times and the cells containing well plates were incubated at 37 °C using a 5% CO2 incubator (24 h). Followed by incubation, MTT (20 µL of 5 mg/ml) was added to the individual well plate. The cells containing well plates were again incubated for another 2 to 4 h until purple-colored precipitates were visible under an inverted microscope. At last, the medium along with MTT (220µL) was detached from the wells and washed with 1X PBS (200 µL). In addition, the formazan crystals in the wash well plate were dissolved by adding DMSO (100µL) and were agitated for 5 min. The absorbance for each well was measured at 570 nm using a microplate reader (Thermo Fisher Scientific, USA), and the percentage cell viability and IC50 value were calculated using Graph Pad Prism 6.0 software (USA) [32].
Anti-SARS CoV2 assay-pseudovirion assay for SARS CoV2
The assay is based on the lentiviral backbone expressing ZsGreen as a traceable marker. We have utilized stable HEK293T expressing human ACE2 as the SARS permissive cells. The procedure involves transfection of HEK Lenti Cells (Invitrogen) with the expression vector encoding ZsGreen, a plasmid expressing spike, and plasmids expressing the minimal set of lentiviral proteins necessary to assemble viral particles (Gag/Pol, Rev). The cells were transfected with the expression vectors prepared via Quiagen Midi prep using lipofectamine 2000 as per the manufacturer’s instruction. After 6 h, the cells were replaced with fresh medium containing serum. SARS CoV2- spike- pseudotype lentiviral particles from the transfected cells were collected at 48 h, filtered using a 0.45-micron filter, and infecting the HEK293T–hACE2 cells using polybrene as per the standard [36, 49].
Data availability
All the necessary data available within the manuscript.
References
Singhal T (2020) A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 87(4):281–286. https://doi.org/10.1007/s12098-020-03263-6
Pal M, Berhanu G, Desalegn C, Kandi V (2020) Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus 12(3):e7423
Baby B, Devan AR, Nair B, Nath LR (2021) The impetus of COVID-19 in multiple organ affliction apart from respiratory infection: pathogenesis, diagnostic measures and current treatment strategy. Infect Disord Drug Targets 21(4):514–526. https://doi.org/10.2174/1871526520999200905115050
Duan L, Zheng Q, Zhang H, Niu Y, Lou Y, Wang H (2020) The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens. Front Immunol 11:2593. https://doi.org/10.3389/fimmu.2020.576622
Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 17(6):613–620. https://doi.org/10.1038/s41423-020-0400-4
Van Hemert MJ, Van Den Worm SH, Knoops K, Mommaas AM, Gorbalenya AE, Snijder EJ (2008) SARS-coronavirus replication/transcription complexes are membr ane-protected and need a host factor for activity in vitro. PLoS Pathog 4(5):e1000054. https://doi.org/10.1371/journal.ppat.1000054
V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V (2021) Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19(3):155–170. https://doi.org/10.1038/s41579-020-00468-6
Ayurveda Products, Services, Consultation and News (2021) https://ayurvedapc.blog/2021/02/09. Accessed 9 Feb 2021
Tiwari V, Darmani NA, Yue BY, Shukla D (2010) In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection. Phytother Res 24(8):1132–1140
Balkrishna A, Khandrika L, Varshney A (2021) Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) reversed SARS-CoV-2 viral spike-protein induced disease phenotype in the xenotransplant model of humanized zebrafish. Front Pharmacol 12:534. https://doi.org/10.3389/fphar.2021.635510
Chavan R, Gohil D, Shah VI, Kothari S, Chowdhary A (2013) Antiviral activity of Indian medicinal plant Justicia adhatoda against herpes simplex virus: an in-vitro study. Int J Pharm Bio Sci 4(4):769–768. https://doi.org/10.22376/ijpbs.2019.10.1.p1-12
Kumar N, Singh S, Manvi RG (2012) Trichosanthes dioica Roxb.: an overview. Pharmacogn Rev 6(11):61–67. https://doi.org/10.4103/0973-7847.95886
Kumar S, Pandey AK (2014) Medicinal attributes of Solanum xanthocarpum fruit consumed by several tribal communities as food: an in vitro antioxidant, anticancer and anti HIV perspective. BMC Complement Altern Med 14(1):1–8. https://doi.org/10.1186/1472-6882-14-112
Yang J, Petitjean SJ, Koehler M, Zhang Q, Dumitru AC, Chen W, Derclaye S, Vincent SP, Soumillion P, Alsteens D (2020) Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun 11(1):4541. https://doi.org/10.1038/s41467-020-18319-6
Lee J, Lee J, Kim HJ, Ko M, Jee Y, Kim S (2021) TMPRSS2 and RNA-dependent RNA polymerase are effective targets of therapeutic intervention for treatment of COVID-19 caused by SARS-CoV-2 variants (B. 1.1. 7 and B. 1.351). Microbiol Spectr 9(1):e00472–21. https://doi.org/10.1128/spectrum.00472-21
Mahmud S, Biswas S, Paul GK, Mita MA, Promi MM, Afrose S, Hasan M, Zaman S, Uddin M, Dhama K, Emran TB (2021) Plant-based phytochemical screening by targeting main protease of SARS-CoV-2 to design effective potent inhibitors. Biology (Basel) 10(7):589. https://doi.org/10.3390/biology10070589
Rafiq M, Nazir Y, Ashraf Z, Rafique H, Afzal S, Mumtaz A, Hassan M, Ali A, Afzal K, Yousuf MR, Saleem M (2019) Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl) amino]-2-oxoethyl derivatives. J Enzyme Inhib Med Chem 34(1):1562–1572. https://doi.org/10.1080/14756366.2019.1654468
Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Molecules 20(7):13384–13421. https://doi.org/10.3390/molecules200713384
Ibrahim ZY, Uzairu A, Shallangwa G, Abechi S (2020) Molecular docking studies, drug-likeness and in-silico ADMET prediction of some novel β-Amino alcohol grafted 1, 4, 5-trisubstituted 1, 2, 3-triazoles derivatives as elevators of p53 protein levels. Sci Afr 10:e00570. https://doi.org/10.1016/j.sciaf.2020.e00570
Attique SA, Hassan M, Usman M, Atif RM, Mahboob S, Al-Ghanim KA, Bilal M, Nawaz MZ (2019) A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension. Int J Environ Res Public Health 16(6):923. https://doi.org/10.3390/ijerph16060923
Baildya N, Ghosh NN, Chattopadhyay AP (2021) Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: an insight from molecular docking and MD-simulation studies. J Mol Struct 1230:129891. https://doi.org/10.1016/j.molstruc.2021.129891
Chen L, Chen H, Dong S, Huang W, Chen L, Wei Y, Shi L, Li J, Zhu F, Zhu Z, Wang Y (2020) The effects of chloroquine and hydroxychloroquine on ACE2-related coronavirus pathology and the cardiovascular system: an evidence-based review. Function (Oxf). 1(2):zqaa012. https://doi.org/10.1093/function/zqaa012
Choudhary S, Silakari O (2020) Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19. Virus Res 289:198146. https://doi.org/10.1016/j.virusres.2020.198146
Nguyen HL, Thai NQ, Truong DT, Li MS (2020) Remdesivir strongly binds to both RNA-dependent RNA polymerase and main protease of SARS-CoV-2: evidence from molecular simulations. J Phys Chem B 124(50):11337–11348. https://doi.org/10.1021/acs.jpcb.0c07312
Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, Bhat S, Stevenson-Leggett P, Zagrajek AK, Hollinghurst P, Varga M (2020) The SARS-CoV-2 spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol 18(12):e3001016. https://doi.org/10.1371/journal.pbio.3001016
Lubbe L, Cozier GE, Oosthuizen D, Acharya KR, Sturrock ED (2020) ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV. Clin Sci (Lond) 134(21):2851–2871. https://doi.org/10.1042/cs20200899
Li Y, Tang S, Yusov A, Rose J, Borrfors AN, Hu CT, Ward MD (2019) Hydrogen-bonded frameworks for molecular structure determination. Nat Commun 10(1):1–7. https://doi.org/10.1038/s41467-019-12453-6
Chen D, Oezguen N, Urvil P, Ferguson C, Dann SM, Savidge TC (2016) Regulation of protein-ligand binding affinity by hydrogen bond pairing. Sci Adv 2(3):e1501240. https://doi.org/10.1126/sciadv.1501240
Abdo N, Moheyeldin O, Shehata MG, El Sohaimy S (2021) Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: molecular docking analysis. Egypt J Chem 64(4):1989–2001. https://doi.org/10.3390/md18120645
Jena AB, Kanungo N, Nayak V, Chainy GB, Dandapat J (2021) Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci Rep 11(1):1–4. https://doi.org/10.1038/s41598-021-81462-7
Kumar A, Saxena AK, Lee GG, Kashyap A, Jyothsna G (2020) Physiochemical characterization and domain annotation of ORF1ab polyprotein of Novel Corona Virus 19. Novel Coronavirus 2019:23–35. https://doi.org/10.1007/978-981-15-7918-9_4
Vishal PK, Oh JM, Khames A, Abdelgawad MA, Nair AS, Nath LR, Gambacorta N, Ciriaco F, Nicolotti O, Kim H, Mathew B (2021) Trimethoxylated halogenated chalcones as dual inhibitors of MAO-B and BACE-1 for the treatment of neurodegenerative disorders. Pharmaceutics 13(6):850. https://doi.org/10.3390/pharmaceutics13060850
Salehi B, Venditti A, Sharifi-Rad M, Kręgiel D, Sharifi-Rad J, Durazzo A, Lucarini M, Santini A, Souto EB, Novellino E, Antolak H (2019) The therapeutic potential of apigenin. Int J Mol Sci 20(6):1305. https://doi.org/10.3390/ijms20061305
Zhang W, Qiao H, Lv Y, Wang J, Chen X, Hou Y, Tan R, Li E (2014) Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors. PLoS ONE 9(10):e110429. https://doi.org/10.1371/journal.pone.0110429
Amano R, Yamashita A, Kasai H, Hori T, Miyasato S, Saito S, Yokoe H, Takahashi K, Tanaka T, Otoguro T, Maekawa S (2017) Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress. Antiviral Res 145:123–130. https://doi.org/10.1016/j.antiviral.2017.07.018
Goc A, Sumera W, Rath M, Niedzwiecki A (2021) Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudovirions. PLoS ONE 16(6):e0253489. https://doi.org/10.1371/journal.pone.0253489
Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, Chand RB, Aparna SR, Mangalapandi P, Samal A (2017) IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics. Sci Rep 8(1):4329. https://doi.org/10.1038/s41598-018-22631-z
Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J (2016) PubChem substance and compound databases. Nucleic Acids Res 44(D1):D1202–D1213. https://doi.org/10.1093/nar/gkv951
Feng Z, Verdiguel N, Di Costanzo L, Goodsell DS, Westbrook JD, Burley SK, Zardecki C (2020) Impact of the Protein Data Bank across scientific disciplines. Data Sci J 19(1):1–14. https://doi.org/10.5334/DSJ-2020-025
Siniprasad P, Nair B, Balasubramaniam V, Sadanandan P, Namboori PK, Nath LR (2020) Evaluation of kaempferol as AKT dependent mTOR regulator via targeting FKBP-12 in hepatocellular carcinoma: an in silico approach. Lett Drug Des Discov 17(11):1401–1408. https://doi.org/10.2174/1570180817999200623115703
Basu A, Sarkar A, Maulik U (2020) Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci Rep 10(1):1–5. https://doi.org/10.1038/s41598-020-74715-4
Doharey PK, Singh V, Gedda MR, Sahoo AK, Varadwaj PK, Sharma B (2021) In silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase. J Biomol Struct Dyn 7:1–8. https://doi.org/10.1080/07391102.2021.1871956
Sahay A, Piprodhe A, Pise M (2020) In silico analysis and homology modeling of strictosidine synthase involved in alkaloid biosynthesis in catharanthus roseus. J Genet Eng Biotechnol 18(1):1–6. https://doi.org/10.1186/s43141-020-00049-3
Balakumar C, Ramesh M, Tham CL, Khathi SP, Kozielski F, Srinivasulu C, Hampannavar GA, Sayyad N, Soliman ME, Karpoormath R (2018) Ligand-and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents. J Biomol Struct Dyn 36(14):3687–3704. https://doi.org/10.1080/07391102.2017.1396255
Tallei TE, Tumilaar SG, Niode NJ, Kepel BJ, Idroes R, Effendi Y, Sakib SA, Emran TB (2020) Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study. Scientifica (Cairo). https://doi.org/10.1155/2020/6307457
Yañez O, Osorio MI, Uriarte E, Areche C, Tiznado W, Pérez-Donoso JM, García-Beltrán O, González-Nilo F (2021) In silico study of coumarins and quinolines derivatives as potent inhibitors of SARS-CoV-2 main protease. Front Chem 8:1273. https://doi.org/10.3389/fchem.2020.595097
Al-Sehemi AG, Olotu FA, Sanal Dev D, Mehboobali Pannipara P, Soliman ME, Carradori S, Mathew B (2020) Natural products database screening for the discovery of naturally occurring SARS-Cov-2 spike glycoprotein blockers. ChemistrySelect 5(42):13309–13317. https://doi.org/10.1002/slct.202003349
Mahrosh HS, Mustafa G (2021) An in silico approach to target RNA-dependent RNA polymerase of COVID-19 with naturally occurring phytochemicals. Environ Dev Sustain 3:1–14. https://doi.org/10.1007/s10668-021-01373-5
Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C (2020) Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell Res 30(4):343–355. https://doi.org/10.1038/s41422-020-0305-x
Acknowledgements
We thank Dr. T.R Santhosh Kumar, Scientist G & Dr. Santik S.L, Post-doctoral fellow, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, for performing Pseudo virion analysis. We thank Dr. Shanthi Kumar. V. Nair, Dean of Research, Amrita Institute of Medical Science and Research Centre, and Dr. Sabitha M, Principal of Amrita School of Pharmacy.
Funding
The work is supported as a part of the Amrita Rapid COVID Response initiative to LRN. The Amrita Vishwa Vidyapeetham PG student grant to MM also supports the project.
Author information
Authors and Affiliations
Contributions
LRN and ATP designed, conceptualised, and wrote the article. MM and BLN wrote the article, MM and VVR performed in silico analysis.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Murali, M., Nair, B., Vishnu, V.R. et al. 2,4-Dihydroxycinnamic acid as spike ACE2 inhibitor and apigenin as RdRp inhibitor in Nimbamritadi Panchatiktam Kashayam against COVID-19: an in silico and in vitro approach. Mol Divers 27, 2353–2363 (2023). https://doi.org/10.1007/s11030-022-10552-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-022-10552-z